Skip to Main Content

Masuda Funai Represents Marlabs in a Strategic Partnership


Press Release

CHICAGO - Masuda, Funai, Eifert & Mitchell, Ltd. represented Marlabs, Inc. (“Marlabs”), a digital services company, in a deal with BV Investments Partners, a middle market private equity firm focused on technology, software and IT services industries, which made a significant, growth investment in Marlabs.

Marlabs is an end-to-end IT services provider enabling its clients to build and manage IT applications and infrastructure. The firm delivers its services to healthcare, life sciences and financial services industries. The firm has over 900 U.S. employees and 1,500 in India.

BV Investment Partners is one of the oldest and most experienced sector-focused private equity firms in North America. Since its founding in 1983, the firm has invested approximately $4.3 billion, actively targeting investments in the tech-enabled business services, software, and IT services industries.

Masuda, Funai, Eifert & Mitchell, Ltd. Deal Team Lawyers:

Jennifer R.M.C. Watson, Gregory M. Wright, Riebana E. Sachs, Yusuke Iino and Jonathan Park

About Masuda, Funai, Eifert & Mitchell, Ltd.

Masuda Funai is a full-service corporate law firm, headquartered in Chicago, representing clients operating and investing throughout the United States. The firm services clients in every aspect of business, including: establishing, acquiring, and financing operations; ownership, development and leasing of real estate; employment, labor, and benefits counseling; dispute resolution; intellectual property rights; business litigation; patent and other intellectual property litigation; creditors' rights; business risk management; legal and regulatory compliance; and structuring the distribution and sale of goods and services throughout the U.S. Masuda Funai services a diverse client base across many industries, including real estate, finance; manufacturing; transportation and logistics; construction and development; professional services; electronics and technology; food, pharma and consumer products; and investment.

# # #